PACKAGE LEAFLET: INFORMATION FOR THE USER
Pravafenix 40mg/160mg hard capsules
pravastatin sodium/fenofibrate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Pravafenix contains two active substances: pravastatin and fenofibrate. Both are cholesterol/lipid-modifying medicines.
Pravafenix is used in combination with a low-fat diet in adults
What should you know about cholesterol and triglycerides?
Cholesterol is one of the different types of fat present in the blood. Total cholesterol is mainly made up of LDL cholesterol and HDL cholesterol.
LDL cholesterol is known as "bad" cholesterol because it can build up in the walls of the arteries and form plaques. Over time, the buildup of plaques can block the arteries, slowing or stopping the flow of blood to vital organs such as the heart and brain. When the flow is blocked, it can cause a heart attack or stroke.
HDL cholesterol is known as "good" cholesterol because it helps prevent "bad" cholesterol from building up in the arteries and protects against heart disease.
Triglycerides are another type of fat present in the blood that can increase the risk of heart problems.
In most people, cholesterol problems go unnoticed at first. Your doctor can find out your cholesterol levels with a simple blood test. Visit your doctor regularly to have your cholesterol checked.
Pravafenix is used in adult patients with a high risk of coronary heart disease to reduce blood cholesterol and triglyceride levels when "bad" cholesterol levels are adequately controlled with pravastatin or another moderate-intensity statin (cholesterol-reducing medicine) as monotherapy.
Do not take Pravafenix
Do not take Pravafenix if any of the above points apply to you. If you are unsure, consult your doctor or pharmacist before taking Pravafenix.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Pravafenix.
Before taking Pravafenix, you must inform your doctor if you have or have had any medical problems.
Contact your doctor immediately if you experience muscle pain, tenderness to the touch, or muscle weakness without apparent reason: in exceptional cases, muscle problems can be serious, including muscle destruction, which can cause kidney damage and, in very rare cases, death.
Also, inform your doctor or pharmacist if you experience constant muscle weakness. Additional tests and medications may be necessary to diagnose and treat this problem.
The risk of muscle destruction is higher in some patients. Inform your doctor if any of the following points apply to you:
Consult your doctor or pharmacist before taking Pravafenix if you have acute respiratory failure; for example, if you have respiratory problems, such as persistent non-productive cough, general health deterioration, such as fatigue (tiredness), weight loss, shortness of breath, or fever.
If you notice any of these symptoms, stop taking Pravafenix and inform your doctor.
During treatment with this medicine, your doctor will closely monitor you if you are diabetic or have a high risk of developing diabetes. You are more likely to develop diabetes if your blood sugar and fat levels are high, you are overweight, or you have high blood pressure.
Children and adolescents
Pravafenix should not be taken by children under 18 years of age.
Other medicines and Pravafenix
Using Pravafenix with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.It is important that you inform your doctor if you are already receiving treatment with any of the following medicines:
Taking Pravafenix with food, drinks, and alcohol
If you are unsure, follow your doctor's instructions.
Pregnancy and breastfeeding
Do not take Pravafenix if you are pregnant or think you may be pregnant or are planning to become pregnant. If you intend to become pregnant, consult your doctor immediately. The use of this medicine should be discontinued due to the possible risk to the fetus.
Do not take Pravafenix if you are breastfeeding.
Driving and using machines
Pravafenix does not normally affect your ability to drive or use machines. If you experience dizziness, blurred vision, or double vision during treatment, check that you are fit to drive vehicles and use machinery before attempting to do so.
Pravafenix contains lactose and sodium
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
This medicine contains 33.3 mg of sodium (a major component of table salt / cooking salt) in each capsule (including excipients and active ingredients). This is equivalent to 1.7% of the maximum recommended daily intake of sodium for an adult.
Follow the instructions for administration of this medicine exactly as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.
The recommended dose is one capsule per day, taken with dinner. The capsule should be swallowed with water, and it is essential to take it with food, as it does not work as effectively on an empty stomach.
If your doctor has prescribed Pravafenix with cholestyramine or other bile acid sequestrants (cholesterol-reducing medicines), take Pravafenix 1 hour before, or 4 to 6 hours after the resin. This is because cholestyramine or other bile acid sequestrants often reduce the absorption of medicines when not taken at a sufficient distance, which can prevent the absorption of Pravafenix. If you need antacids (used to neutralize stomach acid), wait one hour to take Pravafenix.
If you take more Pravafenix than you should
Consult your doctor or pharmacist.
If you forget to take Pravafenix
Do not take a double dose to make up for forgotten doses. Simply take your normal dose of Pravafenix at the usual time the next day.
If you stop taking Pravafenix
Do not stop taking Pravafenix without talking to your doctor first.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following two side effects are important and require immediate action.
Tell your doctor immediately if you experience pain or cramps, tenderness to the touch, or muscle weakness without apparent reason; in exceptional cases (can affect up to 1 in 10,000 people), muscle problems can be serious, including muscle destruction, which can cause kidney damage and, in very rare cases, death.
Severe allergic reactions with swelling of the face, lips, tongue, or trachea can greatly impair breathing. This is a very rare reaction, but it can be serious if it occurs. If it occurs, you must inform your doctor immediately.
Other side effects
Common side effects (can affect up to 1 in 10 people)
Uncommon side effects (can affect up to 1 in 100 people)
Rare side effects (can affect up to 1 in 1,000 people)
Very rare side effects (can affect up to 1 in 10,000 people).
Side effects of unknown frequency (frequency cannot be estimated from the available data)
Possible side effects reported with some statins (a type of cholesterol-reducing medicine, such as pravastatin)
Reporting side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the blister or bottle after 'CAD'. The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Do not throw any medicine away via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Pravafenix
Appearance of the Product and Package Contents
The capsules are hard and gelatinous, with an olive green cap and a light green body containing a beige-white waxy mass and a tablet. The capsules are presented in polyamide-aluminum-PVC/aluminum blisters containing 30, 60, or 90 capsules, and in opaque white plastic bottles containing 14, 30, 60, or 90 capsules.
Only certain pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder Manufacturer
Laboratoires SMB s.a. SMB Technology s.a.
Rue de la Pastorale, 26-28 Rue du Parc Industriel 39
B-1080 Brussels B-6900 Marche-en-Famenne
Belgium Belgium
For more information about this medicine, please contact the local representative of the marketing authorization holder:
Belgium Laboratoires SMB S.A. Tel: + 32.2.411.48.28. | Lithuania Laboratoires SMB S.A. Tel: + 32.2.411.48.28. |
Greece Laboratoires SMB S.A. Tel: + 32.2.411.48.28. | Luxembourg Laboratoires SMB S.A. Tel: + 32.2.411.48.28. |
Czech Republic Laboratoires SMB S.A. Tel: + 32.2.411.48.28. | Hungary Laboratoires SMB S.A. Tel: + 32.2.411.48.28. |
Denmark Laboratoires SMB S.A. Tlf: + 32.2.411.48.28. | Malta Laboratoires SMB S.A. Tel: + 32.2.411.48.28. |
Germany Galephar Pharma GmbH Tel: +49 7164 66 26 | Netherlands Galephar B.V. Tel: +31 71 562 15 02 |
Estonia Laboratoires SMB S.A. Tel: + 32.2.411.48.28. | Norway Laboratoires SMB S.A. Tlf: + 32.2.411.48.28. |
Greece Meditrina LTD Tel: +30 2106726260 | Austria Laboratoires SMB S.A. Tel: + 32.2.411.48.28. |
Spain Lacer S.A. Tel: +34 934 46 53 00 | Poland Laboratoires SMB S.A. Tel: + 32.2.411.48.28. |
France Laboratoires SMB S.A. Tel: + 32.2.411.48.28. | Portugal Tecnimede Sociedade Técnico-Medicinal S.A. Tel: +351 21 041 41 00 |
Croatia Laboratoires SMB S.A. Tel: + 32.2.411.48.28. | Romania Meditrina Pharmaceuticals S.r.l Tel: +40 21 211 71 83 |
Ireland Laboratoires SMB S.A. Tel: + 32.2.411.48.28. | Slovenia Laboratoires SMB S.A. Tel: + 32.2.411.48.28. |
Iceland Laboratoires SMB S.A. Phone: + 32.2.411.48.28. | Slovakia Laboratoires SMB S.A. Tel: + 32.2.411.48.28. |
Italy Laboratoires SMB S.A. Tel: + 32.2.411.48.28. | Finland Laboratoires SMB S.A. Phone/Tel: + 32.2.411.48.28. |
Cyprus Multi-Pharm Co. Ltd. Tel: +357 22438443 | Sweden Laboratoires SMB S.A. Tlf: + 32.2.411.48.28. |
Latvia Laboratoires SMB S.A. Tel: + 32.2.411.48.28. | United Kingdom(Northern Ireland) Laboratoires SMB S.A. Tel: + 32.2.411.48.28. |
Date of the last revision of this leaflet: 21-10-2024
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu/.
The average price of PRAVAFENIX 40 mg/160 mg HARD CAPSULES in October, 2025 is around 23.59 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.